Patients with MASLD often present with deranged liver function tests (LFTs), including elevated levels of liver enzymes, mainly alanine aminotransferase (ALT) and aspartate aminotransferase (AST) [5]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.